Faeth Therapeutics Raises $47 Million To Advance Clinical Trials And Feed The Fight Against Cancer
Amount Raised
$47 Million
Round Type
Funding Round
AustinBiotechnologyHealth CareMedicalTherapeuticsresearchDescription
Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round of private financing led by S2G Ventures, bringing total funding to date to $67 million. The proceeds of the financing will be used to advance Faeth's clinical trials that combine nutrient control, therapeutics and digital tools to inhibit cancer metabolism. Seed round co-lead investors Khosla Ventures and Future Ventures also participated in the Series A, along with additional support from Digitalis, KdT Ventures, AgFunder, and Cantos.
Who to call at Faeth Therapeutics, and when
A new round usually means Faeth Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Faeth Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Faeth Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Faeth Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Faeth Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Faeth Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.